Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma

Tohru Nakagawa, Yae Kanai, Hiroyuki Nakanishi, Motokiyo Komiyama, Hiroyuki Fujimoto

研究成果: Article

5 引用 (Scopus)

抄録

Objective: The aim of this study was to identify clinicopathological variables associated with the clinical outcomes of patients with lymph node metastasis-positive urothelial bladder carcinoma after radical cystectomy. Methods: Forty-six patients who underwent radical cystectomy without preoperative chemotherapy and had histologically proven nodal metastasis were included in the study. The status of lymph nodes and primary lesion was analyzed in terms of disease-specific survival and recurrence-free survival. Results: The 5-year disease-specific survival and recurrence-free survival for the 46 patients overall were 41.3 and 32.2%, respectively. Univariate analysis showed that pN status, the total number of involved lymph nodes, lymph node density and extranodal invasion were statistically significant variables predictive of disease-specific survival. Multivariate analysis revealed that the total number of involved lymph nodes, extranodal invasion and diameter of the metastatic lesion were statistically significant variables predictive of disease-specific survival. Interestingly, the diameter of metastatic lesions was inversely correlated with poorer survival. Patients with large (≥10 mm) metastatic lesions and no extranodal invasion (expansive growth) had significantly better disease-specific survival than those with multiple small (<10 mm) metastatic lesions and no extranodal invasion (highly spreading) (P = 0.0156) or those with extranodal invasion (infiltrative growth) (P = 0.0181). Conclusions: Our data indicate that the clinical outcome of node-positive patients is not only stratified according to the tumor burden reflected in the total number of involved lymph nodes, but also affected by tumor biology including invasiveness and potential for metastasis, which is reflected in pathological characteristics such as extranodal invasion and the diameter of metastatic lesions.

元の言語English
記事番号hys136
ページ(範囲)1066-1072
ページ数7
ジャーナルJapanese Journal of Clinical Oncology
42
発行部数11
DOI
出版物ステータスPublished - 2012 11
外部発表Yes

Fingerprint

Cystectomy
Urinary Bladder
Lymph Nodes
Neoplasm Metastasis
Carcinoma
Survival
Recurrence
Growth
Tumor Burden
Multivariate Analysis
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

これを引用

Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma. / Nakagawa, Tohru; Kanai, Yae; Nakanishi, Hiroyuki; Komiyama, Motokiyo; Fujimoto, Hiroyuki.

:: Japanese Journal of Clinical Oncology, 巻 42, 番号 11, hys136, 11.2012, p. 1066-1072.

研究成果: Article

Nakagawa, Tohru ; Kanai, Yae ; Nakanishi, Hiroyuki ; Komiyama, Motokiyo ; Fujimoto, Hiroyuki. / Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma. :: Japanese Journal of Clinical Oncology. 2012 ; 巻 42, 番号 11. pp. 1066-1072.
@article{f02779a034854fbabc47833dda77c4a2,
title = "Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma",
abstract = "Objective: The aim of this study was to identify clinicopathological variables associated with the clinical outcomes of patients with lymph node metastasis-positive urothelial bladder carcinoma after radical cystectomy. Methods: Forty-six patients who underwent radical cystectomy without preoperative chemotherapy and had histologically proven nodal metastasis were included in the study. The status of lymph nodes and primary lesion was analyzed in terms of disease-specific survival and recurrence-free survival. Results: The 5-year disease-specific survival and recurrence-free survival for the 46 patients overall were 41.3 and 32.2{\%}, respectively. Univariate analysis showed that pN status, the total number of involved lymph nodes, lymph node density and extranodal invasion were statistically significant variables predictive of disease-specific survival. Multivariate analysis revealed that the total number of involved lymph nodes, extranodal invasion and diameter of the metastatic lesion were statistically significant variables predictive of disease-specific survival. Interestingly, the diameter of metastatic lesions was inversely correlated with poorer survival. Patients with large (≥10 mm) metastatic lesions and no extranodal invasion (expansive growth) had significantly better disease-specific survival than those with multiple small (<10 mm) metastatic lesions and no extranodal invasion (highly spreading) (P = 0.0156) or those with extranodal invasion (infiltrative growth) (P = 0.0181). Conclusions: Our data indicate that the clinical outcome of node-positive patients is not only stratified according to the tumor burden reflected in the total number of involved lymph nodes, but also affected by tumor biology including invasiveness and potential for metastasis, which is reflected in pathological characteristics such as extranodal invasion and the diameter of metastatic lesions.",
keywords = "Bladder cancer, Extranodal invasion, Lymph node, Metastasis, Radical cystectomy",
author = "Tohru Nakagawa and Yae Kanai and Hiroyuki Nakanishi and Motokiyo Komiyama and Hiroyuki Fujimoto",
year = "2012",
month = "11",
doi = "10.1093/jjco/hys136",
language = "English",
volume = "42",
pages = "1066--1072",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma

AU - Nakagawa, Tohru

AU - Kanai, Yae

AU - Nakanishi, Hiroyuki

AU - Komiyama, Motokiyo

AU - Fujimoto, Hiroyuki

PY - 2012/11

Y1 - 2012/11

N2 - Objective: The aim of this study was to identify clinicopathological variables associated with the clinical outcomes of patients with lymph node metastasis-positive urothelial bladder carcinoma after radical cystectomy. Methods: Forty-six patients who underwent radical cystectomy without preoperative chemotherapy and had histologically proven nodal metastasis were included in the study. The status of lymph nodes and primary lesion was analyzed in terms of disease-specific survival and recurrence-free survival. Results: The 5-year disease-specific survival and recurrence-free survival for the 46 patients overall were 41.3 and 32.2%, respectively. Univariate analysis showed that pN status, the total number of involved lymph nodes, lymph node density and extranodal invasion were statistically significant variables predictive of disease-specific survival. Multivariate analysis revealed that the total number of involved lymph nodes, extranodal invasion and diameter of the metastatic lesion were statistically significant variables predictive of disease-specific survival. Interestingly, the diameter of metastatic lesions was inversely correlated with poorer survival. Patients with large (≥10 mm) metastatic lesions and no extranodal invasion (expansive growth) had significantly better disease-specific survival than those with multiple small (<10 mm) metastatic lesions and no extranodal invasion (highly spreading) (P = 0.0156) or those with extranodal invasion (infiltrative growth) (P = 0.0181). Conclusions: Our data indicate that the clinical outcome of node-positive patients is not only stratified according to the tumor burden reflected in the total number of involved lymph nodes, but also affected by tumor biology including invasiveness and potential for metastasis, which is reflected in pathological characteristics such as extranodal invasion and the diameter of metastatic lesions.

AB - Objective: The aim of this study was to identify clinicopathological variables associated with the clinical outcomes of patients with lymph node metastasis-positive urothelial bladder carcinoma after radical cystectomy. Methods: Forty-six patients who underwent radical cystectomy without preoperative chemotherapy and had histologically proven nodal metastasis were included in the study. The status of lymph nodes and primary lesion was analyzed in terms of disease-specific survival and recurrence-free survival. Results: The 5-year disease-specific survival and recurrence-free survival for the 46 patients overall were 41.3 and 32.2%, respectively. Univariate analysis showed that pN status, the total number of involved lymph nodes, lymph node density and extranodal invasion were statistically significant variables predictive of disease-specific survival. Multivariate analysis revealed that the total number of involved lymph nodes, extranodal invasion and diameter of the metastatic lesion were statistically significant variables predictive of disease-specific survival. Interestingly, the diameter of metastatic lesions was inversely correlated with poorer survival. Patients with large (≥10 mm) metastatic lesions and no extranodal invasion (expansive growth) had significantly better disease-specific survival than those with multiple small (<10 mm) metastatic lesions and no extranodal invasion (highly spreading) (P = 0.0156) or those with extranodal invasion (infiltrative growth) (P = 0.0181). Conclusions: Our data indicate that the clinical outcome of node-positive patients is not only stratified according to the tumor burden reflected in the total number of involved lymph nodes, but also affected by tumor biology including invasiveness and potential for metastasis, which is reflected in pathological characteristics such as extranodal invasion and the diameter of metastatic lesions.

KW - Bladder cancer

KW - Extranodal invasion

KW - Lymph node

KW - Metastasis

KW - Radical cystectomy

UR - http://www.scopus.com/inward/record.url?scp=84868122035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868122035&partnerID=8YFLogxK

U2 - 10.1093/jjco/hys136

DO - 10.1093/jjco/hys136

M3 - Article

C2 - 22914320

AN - SCOPUS:84868122035

VL - 42

SP - 1066

EP - 1072

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 11

M1 - hys136

ER -